Anixa Biosciences Secures Canadian Patent for Ovarian Cancer Vaccine

Published: 2026-06-01 20:57:09Z Author: Suarez Del Pito Technology

Anixa Biosciences has strengthened its international patent protection with a Canadian notice of allowance for its ovarian cancer vaccine technology.